More articles about: Cancer: Cancer Types

AI can predict certain forms of esophageal and stomach cancer Michigan Medicine study says.

A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.

A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer.

An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.

After an awake surgery to remove a cancerous brain tumor, a Michigan man is living “more deliberately” than ever — officiating a high school wrestling state championship and participating in research for a potential cure.

Research, led by Michigan Medicine and the University of Michigan, suggests that glioblastoma cells are poised near a “critical point” of order and disorder — meaning, the cells possess some form of large-scale coordination throughout the whole tumor that allows them to respond in practical unison to attempts to kill tumor cells, such as chemotherapy or radiation.

Financial toxicity of cancer impacts partners’ quality of life, with people reporting pain, fatigue and sleep issues tied to missed work and medical bills

Protein degrader shows promise against STAT5, which plays a role in leukemia and other cancers

University of Michigan Rogel Cancer Center researchers find ZMYND8 gene plays a critical role in conferring radiation resistance on brain tumors with IDH1 mutation.

William Moldwin published a book, won awards and is making more plans for his future.

Radiation, used to treat half of all cancer patients, can be measured during treatment for the first time with precise 3D imaging developed at the University of Michigan.

In mouse models and serum samples, an FDA-approved drug that lowers ammonia levels made the tumors more sensitive to treatment.

Andrew Ackerman was the first COVID-19 patient to be treated with an experimental filter that reduced his inflammation, helping to save his life.

The anti-cancer effect of the drug may help those with rare, hereditary cancer syndromes avoid surgeries by shrinking tumors via a daily oral dose.

New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.